Compare Becton Dickinson and Co (BDX) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Becton Dickinson and Co trades at $155.79 (market cap $41.51B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.8. The key difference: Becton Dickinson and Co pays a 2.79% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| BDX | HYG | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Fixed Income |
52-Week High | $185.39 | $81.32 |
52-Week Low | $135.49 | $78.72 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
HYG trades at $79.52, down 0.24% with a bearish technical outlook indicated by 17 sell signals against 2 buy signals. The ETF maintains dividend distributions, with recent payouts of $0.42 in May 2026 and $0.41 in June 2026. Market sentiment is cautious amid Federal Reserve uncertainty and elevated put volume in high-yield bonds, reflecting investor concerns about interest rate hikes and inflation pressures.
Outlook remains challenged by macroeconomic headwinds and potential Fed tightening, though dividend yield provides income support. Key risks include interest rate volatility and narrowing market breadth. Investors should weigh yield attractiveness against duration risk in a rising rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →
